Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2020-11-12

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2020-11-12 (fiscal Q3 2020): 47 published measures, 137 facts as tagged in accession 0001161697-20-000481.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-12
Fiscal period
fiscal Q3 2020
Accession
0001161697-20-000481 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3045,434,452USD
At 2019-12-3113,881,861USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-305,493,073USD
At 2019-12-312,645,781USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-3039,941,379USD
At 2020-06-3039,247,254USD
At 2020-03-3112,131,976USD
At 2019-12-3111,236,080USD
At 2019-09-3011,008,792USD
At 2019-06-309,505,018USD
At 2019-03-319,170,722USD
At 2018-12-318,960,807USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3032,433,811USD
At 2019-12-315,870,929USD
At 2019-09-305,129,028USD
At 2018-12-313,738,803USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30249,175USD92
2020-01-01 to 2020-09-30-377,435USD274
2020-04-01 to 2020-06-30-1,076,038USD91
2020-01-01 to 2020-03-31449,428USD91
2019-07-01 to 2019-09-30651,813USD92
2019-01-01 to 2019-09-30644,606USD273
2019-04-01 to 2019-06-3078,183USD91
2019-01-01 to 2019-03-31-85,390USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30968,437USD274
2019-01-01 to 2019-09-30-502,014USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-07-01 to 2020-09-306,080,315USD92
2020-01-01 to 2020-09-3020,119,228USD274
2019-07-01 to 2019-09-306,617,397USD92
2019-01-01 to 2019-09-3016,940,487USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-3026,601,984USD274
2019-01-01 to 2019-09-30502,958USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-1,007,539USD274
2019-01-01 to 2019-09-301,389,281USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-304,487,382USD
At 2019-12-314,864,817USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-07-01 to 2020-09-3043,914,542shares92
2020-01-01 to 2020-09-3041,326,815shares274
2019-07-01 to 2019-09-3039,022,298shares92
2019-01-01 to 2019-09-3038,534,021shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-07-01 to 2020-09-3044,119,511shares92
2020-01-01 to 2020-09-3041,326,815shares274
2019-07-01 to 2019-09-3039,298,408shares92
2019-01-01 to 2019-09-3038,734,083shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2020-07-01 to 2020-09-300.01USD/shares92
2020-01-01 to 2020-09-30-0.01USD/shares274
2019-07-01 to 2019-09-300.02USD/shares92
2019-01-01 to 2019-09-300.02USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2020-07-01 to 2020-09-300.01USD/shares92
2020-01-01 to 2020-09-30-0.01USD/shares274
2019-07-01 to 2019-09-300.02USD/shares92
2019-01-01 to 2019-09-300.02USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-07-01 to 2020-09-30143,353USD92
2020-01-01 to 2020-09-30316,200USD274
2019-07-01 to 2019-09-30186,681USD92
2019-01-01 to 2019-09-30189,265USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-301,260,675USD
At 2019-12-31611,846USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-301,191,146USD274
2019-01-01 to 2019-09-30897,300USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30358,826USD92
2020-01-01 to 2020-09-30-90,352USD274
2019-07-01 to 2019-09-30824,484USD92
2019-01-01 to 2019-09-30745,323USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3042,648,042USD
At 2019-12-3111,881,323USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-305,361,430USD
At 2019-12-312,406,289USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-301,363,070USD
At 2019-12-31572,656USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-09-30884,635USD
At 2019-12-31807,135USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-303,736,596USD
At 2019-12-313,234,521USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2019-01-01 to 2019-09-302,820USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,581,897USD92
2020-01-01 to 2020-09-3012,729,165USD274
2019-07-01 to 2019-09-303,558,424USD92
2019-01-01 to 2019-09-3010,161,203USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-305,633,139USD
At 2019-12-312,388,477USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,940,723USD92
2020-01-01 to 2020-09-3012,638,813USD274
2019-07-01 to 2019-09-304,382,908USD92
2019-01-01 to 2019-09-3010,906,526USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,075,169USD92
2020-01-01 to 2020-09-309,039,980USD274
2019-07-01 to 2019-09-302,441,381USD92
2019-01-01 to 2019-09-306,976,684USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-30390,416USD92
2020-01-01 to 2020-09-30944,637USD274
2019-07-01 to 2019-09-30170,260USD92
2019-01-01 to 2019-09-30450,454USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3043,934,576shares
At 2019-12-3139,502,557shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-30271,679USD
At 2019-12-31373,734USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-30271,679USD
At 2019-12-31373,734USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-09-303,148,866USD
At 2019-12-312,431,085USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-09-301,888,191USD
At 2019-12-311,819,239USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-09-3019,812USD
At 2019-12-3119,582USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-303,051,582USD
At 2019-12-311,296,612USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-07-01 to 2020-09-3099,071USD92
2020-01-01 to 2020-09-30251,084USD274
2019-07-01 to 2019-09-3069,740USD92
2019-01-01 to 2019-09-30218,328USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-07-01 to 2020-09-30115,637USD92
2020-01-01 to 2020-09-30297,801USD274
2019-07-01 to 2019-09-3082,774USD92
2019-01-01 to 2019-09-30252,594USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-07-01 to 2020-09-309,662USD92
2020-01-01 to 2020-09-3023,690USD274
2019-07-01 to 2019-09-3023,368USD92
2019-01-01 to 2019-09-3059,091USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-3033,702USD92
2020-01-01 to 2020-09-3029,117USD274
2019-07-01 to 2019-09-3014,010USD92
2019-01-01 to 2019-09-3088,548USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-09-3027,698USD274
2019-01-01 to 2019-09-30280USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2020-01-01 to 2020-09-30318,983USD274
2019-01-01 to 2019-09-30103,465USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-09-3026,606,486USD274
2019-01-01 to 2019-09-30508,900USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-01-01 to 2020-09-30113,764USD274
2019-01-01 to 2019-09-30111,672USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30502,075USD274
2019-01-01 to 2019-09-302,120,780USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-303,244,662USD274
2019-01-01 to 2019-09-30634,803USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30790,414USD274
2019-01-01 to 2019-09-30421,479USD273

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))